Pages that link to "Q51095167"
Jump to navigation
Jump to search
The following pages link to Lithium does not attenuate the effects of D-amphetamine in healthy volunteers (Q51095167):
Displaying 16 items.
- Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients (Q28279000) (← links)
- Animal models of bipolar mania: The past, present and future. (Q30357298) (← links)
- Amphetamine increases activity but not exploration in humans and mice (Q30367024) (← links)
- Predictive animal models of mania: hits, misses and future directions (Q30462823) (← links)
- Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients (Q30916998) (← links)
- GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior (Q33590698) (← links)
- Behavioral and pharmacological assessment of a potential new mouse model for mania (Q34850726) (← links)
- The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited (Q35054681) (← links)
- Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania (Q36510848) (← links)
- Locomotor Profiling from Rodents to the Clinic and Back Again (Q38897374) (← links)
- Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium (Q40262756) (← links)
- Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study (Q44233171) (← links)
- Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers (Q44453910) (← links)
- Effects of chronic lithium and sodium valproate on concentrations of brain amino acids (Q44530627) (← links)
- Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania (Q48542681) (← links)
- Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania. (Q53444102) (← links)